跳转至内容
Merck
  • Developing a human iPSC-derived three-dimensional myelin spheroid platform for modeling myelin diseases.

Developing a human iPSC-derived three-dimensional myelin spheroid platform for modeling myelin diseases.

iScience (2023-10-23)
Lizhao Feng, Jianfei Chao, Mingzi Zhang, Elizabeth Pacquing, Weidong Hu, Yanhong Shi
摘要

Myelin defects cause a collection of myelin disorders in the brain. The lack of human models has limited us from better understanding pathological mechanisms of myelin diseases. While human induced pluripotent stem cell (hiPSC)-derived spheroids or organoids have been used to study brain development and disorders, it has been difficult to recapitulate mature myelination in these structures. Here, we have developed a method to generate three-dimensional (3D) myelin spheroids from hiPSCs in a robust and reproducible manner. Using this method, we generated myelin spheroids from patient iPSCs to model Canavan disease (CD), a demyelinating disorder. By using CD patient iPSC-derived myelin spheroids treated with N-acetyl-aspartate (NAA), we were able to recapitulate key pathological features of the disease and show that high-level NAA is sufficient to induce toxicity on myelin sheaths. Our study has established a 3D human cellular platform to model human myelin diseases for mechanistic studies and drug discovery.

材料
货号
品牌
产品描述

Sigma-Aldrich
N6,2′-O-二丁酰基腺苷 3′,5′-环单磷酸 钠盐, ≥96% (HPLC), powder
Sigma-Aldrich
抗-神经丝200 兔抗, IgG fraction of antiserum, buffered aqueous solution
Sigma-Aldrich
SAG 二盐酸盐, ≥98% (HPLC)
Sigma-Aldrich
抗-髓磷脂少突胶质细胞糖蛋白(MOG)抗体, clone 8-18C5, Chemicon®, from mouse